January 12, 2011

Company announcements: WILLOW, CUSCAPI, GDEX, TMCLIFE

WILLOW - Notice of Shares Buy Back - Immediate Announcement

Announcement Type: Notice of Shares Buy Back - Immediate Announcement
Company Name: WILLOWGLEN MSC BERHAD
Stock Name: WILLOW
Date Announced: 12/01/2011

Announcement Detail:
Date of buy back: 12/01/2011

Description of shares purchased: Ordinary shares of RM0.10 each

Currency: Malaysian Ringgit (MYR)

Total number of shares purchased (units): 158,600

Minimum price paid for each share purchased ($$): 0.375

Maximum price paid for each share purchased ($$): 0.385

Total consideration paid ($$): 61,267.29

Number of shares purchased retained in treasury (units): 158,600

Number of shares purchased which are proposed to be cancelled (units): 0

Cumulative net outstanding treasury shares as at to-date (units): 3,170,300

Total number of shares purchased and/or held as treasury shares against the total number of outstanding shares of the listed issuer (%): 1.29


CUSCAPI - General Announcement

Announcement Type: General Announcement
Submitting Merchant Bank: HWANGDBS INVESTMENT BANK BERHAD
Company Name: CUSCAPI BERHAD (ACE Market)
Stock Name: CUSCAPI
Date Announced: 12/01/2011

Announcement Detail:
Type: Announcement

Subject: CUSCAPI BERHAD ("CUSCAPI" OR "COMPANY")
I. PROPOSED ESTABLISHMENT OF AN EMPLOYEES' SHARE OPTION SCHEME FOR THE ELIGIBLE DIRECTORS AND EMPLOYEES OF CUSCAPI AND ITS SUBSIDIARY COMPANIES ("PROPOSED ESOS"); AND
II. PROPOSED AUTHORITY FOR THE COMPANY TO PURCHASE UP TO TEN PERCENT (10%) OF ITS ISSUED AND PAID-UP SHARE CAPITAL ("PROPOSED SHARE BUY-BACK)
(COLLECTIVELY KNOWN AS THE "PROPOSALS")

Contents: We refer to the earlier announcement in relation to the Proposals.

On behalf of the Board of Directors of Cuscapi, HwangDBS Investment Bank Berhad ("HwangDBS") wishes to announce that the additional listing application to Bursa Malaysia Securities Berhad in respect of the Proposed ESOS has been submitted today.

This announcement is dated 12 January 2011.


GDEX - Entitlement - Others

Announcement Type: Entitlements (Notice of Book Closure)
Submitting Merchant Bank: HONG LEONG INVESTMENT BANK BERHAD
Company Name: GD EXPRESS CARRIER BERHAD (ACE Market)
Stock Name: GDEX
Date Announced: 12/01/2011

Announcement Detail:
EX-date: 25/01/2011

Entitlement date: 27/01/2011

Entitlement time: 05:00:00 PM

Entitlement subject: Others

Entitlement description: Issue of 51,437,207 free warrants ("Free Warrants") in GD Express Carrier Berhad ("GDEX" or the "Company") on the basis of one (1) Free Warrant for every five (5) ordinary shares of RM0.10 each in GDEX held

Period of interest payment: to

Financial Year End: 30/06/2011

Share transfer book & register of members will be: 27/01/2011 to 27/01/2011 closed from (both dates inclusive) for the purpose of determining the entitlements

Registrar's name ,address, telephone no: Tricor Investor Services Sdn Bhd
Level 17, The Gardens North Tower
Mid Valley City
Lingkaran Syed Putra
59200 Kuala Lumpur
Telephone: (603) 2264 3883
Fax: (603) 2282 1886

a. Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers: 27/01/2011

Entitlement indicator: Ratio

Ratio: 1 : 5

Remarks: The date of listing and quotation of the Free Warrants on the ACE Market of Bursa Malaysia Securities Berhad will be announced in due course.


TMCLIFE - Change in Boardroom

Announcement Type: Change in Boardroom
Company Name: TMC LIFE SCIENCES BERHAD
Stock Name: TMCLIFE
Date Announced: 12/01/2011

Announcement Detail:
Date of change: 12/01/2011

Type of change: Resignation

Designation: Non-Executive Director

Directorate: Independent & Non Executive

Name: Dr. Yap Teck Long

Age: 55

Nationality: Malaysian

Qualifications: -

Working experience and occupation: -

Directorship of public companies (if any): -

Family relationship with any director and/or major shareholder of the listed issuer: Nil

Any conflict of interests that he/she has with the listed issuer: Nil

Details of any interest in the securities of the listed issuer or its subsidiaries: 33,700 ordinary shares of RM0.10 each


TMCLIFE - Change in Boardroom

Announcement Type: Change in Boardroom
Company Name: TMC LIFE SCIENCES BERHAD
Stock Name: TMCLIFE
Date Announced: 12/01/2011

Announcement Detail:
Date of change: 12/01/2011

Type of change: Resignation

Designation: Non-Executive Director

Directorate: Non Independent & Non Executive

Name: Yeoh Cheng Lee

Age: 39

Nationality: Malaysian

Qualifications: -

Working experience and occupation: -

Directorship of public companies (if any): -

Family relationship with any director and/or major shareholder of the listed issuer: Nil

Any conflict of interests that he/she has with the listed issuer: Nil

Details of any interest in the securities of the listed issuer or its subsidiaries: Nil


TMCLIFE - Change in Audit Committee

Announcement Type: Change in Audit Committee
Company Name: TMC LIFE SCIENCES BERHAD
Stock Name: TMCLIFE
Date Announced: 12/01/2011

Announcement Detail:
Date of change: 12/01/2011

Type of change: Resignation

Designation: Chairman of Audit Committee

Directorate: Independent & Non Executive

Name: Dato' Dr. Tan Kee Kwong

Age: 63

Nationality: Malaysian

Qualifications: -

Working experience and occupation: -

Directorship of public companies (if any): Malayan United Industries Berhad

Family relationship with any director and/or major shareholder of the listed issuer: Nil

Any conflict of interests that he/she has with the listed issuer: Nil

Details of any interest in the securities of the listed issuer or its subsidiaries: Nil

Composition of Audit Committee (Name and Directorate of members after change): 1. Mr. Gary Ho Kuat Foong - Independent Non-Executive Director and Chairman of Audit Committee
2. Dr. Lee G. Lam - Independent Non-Executive Director and Member of Audit Committee
3. Mr. Freddie Pang Hock Cheng - Non-Independent Non-Executive Director and Member of Audit Committee


TMCLIFE - Change in Audit Committee

Announcement Type: Change in Audit Committee
Company Name: TMC LIFE SCIENCES BERHAD
Stock Name: TMCLIFE
Date Announced: 12/01/2011

Announcement Detail:
Date of change: 12/01/2011

Type of change: Resignation

Designation: Member of Audit Committee

Directorate: Independent & Non Executive

Name: Dr. Yap Teck Long

Age: 55

Nationality: Malaysian

Qualifications: -

Working experience and occupation: -

Directorship of public companies (if any): -

Family relationship with any director and/or major shareholder of the listed issuer: Nil

Any conflict of interests that he/she has with the listed issuer: Nil

Details of any interest in the securities of the listed issuer or its subsidiaries: 33,700 ordinary shares of RM0.10 each

Composition of Audit Committee (Name and Directorate of members after change): 1. Mr. Gary Ho Kuat Foong - Independent Non-Executive Director and Chairman of Audit Committee
2. Dr. Lee G. Lam - Independent Non-Executive Director and Member of Audit Committee
3. Mr. Freddie Pang Hock Cheng - Non-Independent Non-Executive Director and Member of Audit Committee


TMCLIFE - Change in Boardroom

Announcement Type: Change in Boardroom
Company Name: TMC LIFE SCIENCES BERHAD
Stock Name: TMCLIFE
Date Announced: 12/01/2011

Announcement Detail:
Date of change: 12/01/2011

Type of change: Appointment

Designation: Executive Director

Directorate: Executive

Name: Dr. Wong Chiang Yin

Age: 42

Nationality: Singaporean

Qualifications: MBBS (Singapore)
M. Med (Public Health)
MBA (Finance)
FAMS

Working experience and occupation: March 2010 to September 2010 - Chief Executive Officer - Bright Vision Hospital
May 2008 to May 2009 - Executive Director - Pantai Holdings Berhad
April 2004 to April 2008 - Chief Operating Officer - Changi General Hospital
April 2002 to March 2004 - Chief Operating Officer - Singapore General Hospital

Directorship of public companies (if any): Nil

Family relationship with any director and/or major shareholder of the listed issuer: Nil

Any conflict of interests that he/she has with the listed issuer: Nil

Details of any interest in the securities of the listed issuer or its subsidiaries: Nil


TMCLIFE - Change in Boardroom

Announcement Type: Change in Boardroom
Company Name: TMC LIFE SCIENCES BERHAD
Stock Name: TMCLIFE
Date Announced: 12/01/2011

Announcement Detail:
Date of change: 12/01/2011

Type of change: Appointment

Designation: Non-Executive Director

Directorate: Non Independent & Non Executive

Name: Dr. Chan Boon Kheng

Age: 42

Nationality: Singaporean

Qualifications: Medical Degree from National University of Singapore.
MBA (Honors) from University of Chicago.

Working experience and occupation: Dr. Chan was an Advisor and Interim Group Chief Executive Officer of Pantai Holdings Berhad. He also served as an Advisor to various healthcare companies including Mubadala Development Company based in Abu Dhabi and was Chief Executive Officer and General Manager of East Shore Hospital in Singapore under Parkway Healthcare.

Dr. Chan is the Chairman of Innoheart, a pre-clinical Contract Research Organisation based in Singapore. He is also currently a director of healthcare consultancy companies whose activities ranges from transition management, process improvement, performance management and commercialising bioscience and technology applications.

Directorship of public companies (if any): Nil

Family relationship with any director and/or major shareholder of the listed issuer: Nil

Any conflict of interests that he/she has with the listed issuer: Nil

Details of any interest in the securities of the listed issuer or its subsidiaries: Nil


TMCLIFE - Change in Boardroom

Announcement Type: Change in Boardroom
Company Name: TMC LIFE SCIENCES BERHAD
Stock Name: TMCLIFE
Date Announced: 12/01/2011

Announcement Detail:
Date of change: 12/01/2011

Type of change: Appointment

Designation: Non-Executive Director

Directorate: Independent & Non Executive

Name: Gary Ho Kuat Foong

Age: 55

Nationality: Australian

Qualifications: CPA

Working experience and occupation: October 2006 to present - Non-Executive Director of UPP Holdings Ltd.
May 2002 to December 2002 - Executive Director of Manchester United Food & Beverage (Asia) Pte. Ltd.
March 2000 to November 2001 - Executive Director, Chief Financial Officer of Asiamedic Ltd.
January 1999 to March 2000 - Non-Executive Director of Asiamedic Ltd.

Directorship of public companies (if any): Nil

Family relationship with any director and/or major shareholder of the listed issuer: Nil

Any conflict of interests that he/she has with the listed issuer: Nil

Details of any interest in the securities of the listed issuer or its subsidiaries: Nil



No comments:

Post a Comment